Maxonis is a biotechnology company developing LDP-916 (AGRG), a next-generation regenerative gel for Peripheral Nerve Injury (PNI) and Spinal Cord Injury (SCI). Based on 15+ years of research at Tel Aviv Sourasky Medical Center, LDP-916 uses four FDA-recognized materials to guide axonal regrowth and bridge long nerve gaps. Our mission is to deliver a minimally invasive, scalable, and clinically meaningful solution for true nerve regeneration.
| Website | https://www.maxonis.com |
| Revenue | $1 million |
| Employees | 11 (8 on RocketReach) |
| Founded | 2022 |
| Technologies |
HTML
,
Twitter
,
Cloudflare
+52 more
(view full list)
|
| Industry | Biotechnology Research, Custom Software & Technical Consulting, Software |
| Keywords | Nerve Regeneration, Spinal Cord Injury Treatment, Neurological Rehabilitation, Peripheral Nerve Repair, Neuroscience Research, Regenerative Medicine, Neuromodulation, Stem Cell Therapy, Tissue Engineering, Biomedical Engineering, Medical Devices, Drug Delivery, Clinical Trials, Neurological Disorders, Central Nervous System, Functional Recovery, Neuropathic Pain, Neurological Recovery |
| Competitors | RadNet, DeepHealth, PathAI, Qure.ai, CureMetrix, Zebra Medical Vision Ltd, Aidoc, Imagia, Fathom.ai +33 more (view full list) |
| SIC | SIC Code 737 Companies, SIC Code 73 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Maxonis employee's phone or email?
Maxonis Questions
The Maxonis annual revenue was $1 million in 2026.
Itay Itzhaky is the CEO and Co-founder of Maxonis.
8 people are employed at Maxonis.
The NAICS codes for Maxonis are [541, 54].
The SIC codes for Maxonis are [737, 73].
Top Maxonis Employees
-
Itay Itzhaky
CEO and Co-founder at Maxonis
Center District, Israel1 -
22
-
41
-
Mara Almog
R and D Director at Maxonis
Tel Aviv-Yafo, IL1 -
Yael Nadel
Manager Analytical Development at Maxonis
Tel Aviv District, Israel1 -
Asher Cachlon
Research And Development Manager at Maxonis
Tel Aviv District, Israel1
